1. Aguiar FJ, Ferreira-Júnior M, Sales MM, Cruz-Neto LM, Fonseca LA, Sumita NM, Duarte NJ, Lichtenstein A, Duarte AJ (2013) C-reactive protein: clinical applications and proposals for a rational use. Rev Assoc Med Bras (1992) 59(1):85–92
2. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, Davos CH, Cicoira M, Osterziel KJ, Leyva F, Hetzer R, Ponikowski P, Coats AJ (2003) Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107:1991–1997
3. Anzai T, Yoshikawa T, Shiraki H et al (1997) C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 96:778–784
4. Aznar J, Santos MT, Valles J, Sala J (1983) Serum malondialdehyde-like material (mda-lm) in acute myocardial infarction. J Clin Pathol 36:712–715
5. Baruah M, Nath C, Goyal S et al (2012) Study of c-reactive protein, malondialdehyde and uric acid levels in predicting outcome in acute myocardial infarction. Int J Cur Res Rev 04(19):128–132